BioInvent International AB (publ) (STO:BINV)
Sweden · Delayed Price · Currency is SEK 22.20
+0.30 (1.37%)
Sep 22, 2026, 5:29 PM CET
STO:BINV Market Cap
STO:BINV has a market cap or net worth of 1.44 billion as of September 22, 2026. Its market cap has decreased by -28.55% in one year.
Market Cap
1.44B
Enterprise Value
1.12B
Revenue
32.51M
Ranking
n/a
PE Ratio
n/a
Stock Price
22.20
ChartMarket Cap Chart
Since June 14, 2001, STO:BINV's market cap has increased from 1.20B to 1.44B, an increase of 19.61%. That is a compound annual growth rate of 0.71%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 22, 2026 | 1.44B | -25.51% |
| Dec 30, 2025 | 1.93B | -23.64% |
| Dec 30, 2024 | 2.53B | 103.06% |
| Dec 29, 2023 | 1.25B | -40.08% |
| Dec 30, 2022 | 2.08B | -22.92% |
| Dec 30, 2021 | 2.70B | 54.06% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Hansa Biopharma AB | 3.63B |
| Vicore Pharma Holding AB | 2.89B |
| Flerie AB | 1.50B |
| Genovis AB (publ.) | 1.34B |
| Saniona AB | 1.32B |
| AlzeCure Pharma AB | 1.05B |
| Medivir AB | 1.04B |
| SynAct Pharma AB | 1.00B |